Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03302936 · ClinicalTrials.gov registry record · Phase 4
Assessing Pyridium for Post-Sling Urinary Retention
A Phase 4 study of Urinary Retention, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- Phase 4
- Development phase
- 98
- Enrollment target
- 1
- Study location
NCT03302936: Completed Phase 4 study of Urinary Retention, sponsored by Icahn School of Medicine at Mount Sinai.
NCT03302936 is a Phase 4 study of Urinary Retention that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 98 participants, below the 131-participant average among 11 other Urinary Retention trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03302936, a Phase 4 study of Urinary Retention, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 98 participants
- Enrollment target
- 1
- Study location
Study Summary
There has been preliminary data showing that pyridium can decrease the risk of difficulty urinating after midurethral sling. This study is designed to have two groups of patients. One group will receive pyridium pre-operatively, while the other group will have routine preoperative care. Both groups will have their bladder tested prior to going home. It will be evaluated if there is a difference in the difficulty to urinate post-operatively in both groups.
Primary Outcome
Pyridium affect - A patient's bladder is backfilled with water prior to having foley removed. If they can void 200cc of 300cc instilled in the bladder, they are considered to have past their voiding trial.
Conditions Studied
Interventions
- DRUG Phenazopyridine
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 98 participants |
| Start Date | 2017-10-24 |
| Est. Completion | 2019-07-01 |
| Phase | Phase 4 |
What the finished NCT03302936 record still lists
NCT03302936 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 98 participants, a relatively small participant target, below the 131-participant average among 11 other Urinary Retention trials with a reported enrollment target (25% lower).
The record links to 1 condition, with Urinary Retention appearing as the primary indexed condition, and to 1 intervention - of which Phenazopyridine is the first listed.
NCT03302936 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT03302936 about?
NCT03302936 is a clinical study titled "Assessing Pyridium for Post-Sling Urinary Retention". There has been preliminary data showing that pyridium can decrease the risk of difficulty urinating after midurethral sling. This study is designed to have two groups of patients. One group will receive pyridium pre-operatively, while the other group will have routine preoperative care. Both groups ...
What is the current status of trial NCT03302936?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 98 participants. The study started on 2017-10-24. Estimated completion is 2019-07-01.
What conditions does trial NCT03302936 study?
This clinical trial studies the following conditions: Urinary Retention.
What interventions are being tested in trial NCT03302936?
The interventions under investigation include: Phenazopyridine (DRUG).
Who is sponsoring clinical trial NCT03302936?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03302936 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Retention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03302936's enrollment target sits among peer trials
98 6th of 11 higher than 6 of 11 other Urinary Retention trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Urinary Retention trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery
RECRUITING · Early Phase 1
-
Comparison of Urinary Flow Study
RECRUITING · NA
-
Preoperative Pelvic Floor Physical Therapy to Minimize Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate
RECRUITING · NA
-
How the Method of Bladder Emptying After Epidural Placement in Labor Affects Postpartum Voiding
RECRUITING · NA
-
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
RECRUITING · NA
-
Effect of Chlorhexidine Gluconate Bladder Instillations in Patients With Chronic Suprapubic Catheters on Unplanned Healthcare Encounters and Quality of Life
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02926729 · 98 participants · NA
Real-Time Assessment Of Breast Cancer Lumpectomy Specimen Margins With Nonlinear Microscopy
- NCT03382977 · 98 participants · Phase 1
Study to Evaluate Safety, Tolerability, and Optimal Dose of Candidate GBM Vaccine VBI-1901 in Recurrent GBM Subjects
- NCT04577014 · 98 participants · Phase 1
Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma
- NCT04817618 · 98 participants · Phase 3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI